Ilika sets industrial pace with new solid state battery programme

Ilika Plc

Ilika has unveiled its PRIMED programme, a focused initiative designed to accelerate progress of its Goliath solid state battery technology. Backed by government funding and guided by industry and academic partners, the company has set out a 12-month timetable to deliver prototype cells that can move it closer to commercial viability.

The programme will run at the UK Battery Industrialisation Centre, giving Ilika access to facilities that replicate early stages of large-scale production. Within this framework, the company intends to produce its next generation of P2 prototype cells and assemble 50 amp-hour A-samples that can be evaluated for use in electric vehicles.

An important aspect of PRIMED is the steering committee put in place to oversee direction. Jaguar Land Rover brings an automotive perspective, ensuring design choices and specifications remain aligned with the requirements of future electric platforms. Oxford University, represented by Professor Paul Shearing, adds an academic lens to strengthen technical oversight and maintain scientific rigour.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search